Showing 161 - 180 results of 41,215 for search '(( 50 ((a decrease) OR (teer decrease)) ) OR ( e ((fold decrease) OR (mean decrease)) ))', query time: 0.83s Refine Results
  1. 161
  2. 162

    HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

    Published 2015
    “…[NG+control siRNA = 5mM D-glucose + 100nM control siRNA, HG+control siRNA = 25mM D-glucose + 100nM control siRNA, HG+EZH2 siRNA = 25mM D-glucose + 100nM EZH2 siRNA, HG+SUZ12 siRNA = 25mM + 100nM SUZ12 siRNA; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to U6 or β-actin and expressed as a fold change of NG+control siRNA].…”
  3. 163
  4. 164

    Identification of mutations that impair global folding. by Radhika Gopal (4692103)

    Published 2017
    “…The expression of the V5 tag for each mutant was normalized to V5 expression on wild-type E1E2 (left). Only one mutation T329A (red dot) resulted in markedly decreased V5 expression. …”
  5. 165
  6. 166
  7. 167
  8. 168
  9. 169
  10. 170
  11. 171

    Marimastat decreases hepatic stellate cell (HSC) activation, but increases recruitment of inflammatory cells. by Vincent E. de Meijer (343377)

    Published 2013
    “…Liver sections from animals that were chronically challenged with CCl4 showed that resident T cells (CD3, C,D) and macrophages (F4/80, E,F) counts increased up to 2-fold upon Marimastat treatment. …”
  12. 172
  13. 173
  14. 174

    Ageing results in an abrupt decrease in overall neurogenesis in the mouse DG. by Joana Gil-Mohapel (462002)

    Published 2013
    “…Arrow in (E) indicates a BrdU/NeuN double-labeled cell in the DG of a 9 month-old mouse. …”
  15. 175

    CDDO-Me radioprotection decreases with progressive oncogenic manipulations in HBECs and in a matched NSCLC line. by Mariam El-Ashmawy (678638)

    Published 2014
    “…(F) Increasing concentrations to 50 nM still enhances clonogenic survival of HBEC 30KT, but actually seems to decrease survival in HCC 4017 after 3 Gy radiation. …”
  16. 176

    Viability of microencapsulated FP ICCs decreased with time post-transplantation. by Vijayaganapathy Vaithilingam (390354)

    Published 2013
    “…B) Viability decreased with time post-transplantation. Values are mean ± SEM (n = 100 microcapsules/mice for each time point); *p&lt;0.05 viability for days 7 to 21 when compared to pre-transplantation control and days 1 and 3 post-transplantation; #p&lt;0.05 viability for days 14 and 21 when compared to day 7 post-transplantation (one-way ANOVA with post-hoc Tukey-Kramer Multiple-Comparison test).…”
  17. 177
  18. 178
  19. 179

    rAd-p53 induces apoptosis in HCC cell lines with increased Fbxw7 and decreased c-Myc and Cyclin E. by Kangsheng Tu (428934)

    Published 2013
    “…<p>A) MTT activity was measured after infecting Hep3B cells with rAd-p53 in an MOI gradient to determine their IC<sub>50</sub> after 48 h. …”
  20. 180